CRON$2.60
$2.64
Chart
Performance
Key Stats
AI CRON Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
HoldCronos Group presents a mixed investment profile. While operating in a growing industry with some positive recent performance, significant historical losses and current technical indicators suggest a cautious approach. The company is in a turnaround phase, with future success highly dependent on its ability to consistently achieve profitability and manage operational costs.
Thematic
Cronos Group operates within the burgeoning global cannabis market, which has strong long-term growth potential driven by evolving regulations and increasing consumer acceptance. However, the industry is highly competitive and subject to regulatory shifts and market sentiment.
Fundamental
Cronos Group has shown improving revenue and a return to profitability in its most recent reported quarter after periods of significant losses. However, historical financial performance, particularly concerning net margins and earnings per share, indicates ongoing challenges in achieving consistent profitability. The company holds a strong cash position, which is a positive for financial flexibility.
Technical
Current technical indicators, particularly moving averages and oscillators across various timeframes (1m to 1d), generally suggest a 'Sell' or 'Neutral' action. The price is below key moving averages (e.g., 200-day EMA/SMA) and many shorter-term indicators are signaling bearish momentum, indicating potential for further downside or consolidation.
| Factor | Score |
|---|---|
| Cannabis Market Growth | 85 |
| Regulatory Landscape | 70 |
| Product Innovation | 75 |
| Competitive Environment | 65 |
| ESG & Sustainability | 60 |
| Factor | Score |
|---|---|
| Valuation | 60 |
| Profitability | 40 |
| Growth | 75 |
| Balance Sheet Health | 90 |
| Cash Flow | 65 |
| Earnings Per Share (EPS) | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 50 |
| Volume Confirmation | 60 |
| Support & Resistance | 45 |
| Oscillators (Short-Term) | 35 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Positive Net Income Trend
The company has shown a positive trend in Net Income, turning from significant losses in 2022 and 2023 to a net income of $41.08 million in 2024. This indicates a potential turnaround and improved profitability.
Strong Cash Position
The company ended Q4 2024 with $858.8 million in cash and cash equivalents, a significant increase from $669.3 million in Q4 2023. This strong liquidity provides a buffer against financial uncertainties and supports operational needs.
Bearish Points (7)
High Price-to-Sales (P/S) Ratio
The trailing P/S ratio of 8.1 is relatively high compared to the revenue of $96.83 million, suggesting that the market values the company's revenue stream highly, which could be a risk if revenue growth slows.
Inconsistent EPS
While recent quarters show positive surprises, the historical EPS data from 2022 and 2023 indicates significant losses and negative EPS, highlighting past unprofitability and potential volatility.
Calendar
August 2025
7
Next Earnings Date
H: $
A: $
L: $
H: 45.73M
A: 45.73M
L: 45.73M
Profile
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
Seasonals
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Major Canadian cannabis producer, direct competitor of CRON in Canadian and international markets with similar strategic goals.
Weight: 90
Leading Canadian cannabis producer and distributor, direct competitor with global operations and diversified cannabis product lines.
Weight: 88
Prominent Canadian cannabis producer, direct competitor to CRON with a focus on medical and recreational markets.
Weight: 85
Canadian cannabis company with diversified operations including retail, cultivation, and investments; a direct competitor.